Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Teresa Rodríguez-Jato"'
Autor:
Lorena Rodríguez-Martínez, Ana Castro-Balado, Gonzalo Hermelo-Vidal, Enrique Bandín-Vilar, Iria Varela-Rey, Francisco José Toja-Camba, Teresa Rodríguez-Jato, Ignacio Novo-Veleiro, Pablo Manuel Varela-García, Irene Zarra-Ferro, Miguel González-Barcia, Cristina Mondelo-García, Jesús Mateos, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 15, Iss 8, p 2099 (2023)
Outpatient parenteral antimicrobial therapy (OPAT) with continuous infusion pumps is postulated as a very promising solution to treat complicated infections, such as endocarditis or osteomyelitis, that require patients to stay in hospital during exte
Externí odkaz:
https://doaj.org/article/7b59e2a9259d47b79bd574d5c9dd39b7
Autor:
Sara Blanco-Dorado, Maria Dolores Belles Medall, Francisco J. Otero-Espinar, Rafael Rodríguez-Riego, Teresa Rodríguez-Jato, Anxo Fernández-Ferreiro, Manuel Campos-Toimil, María Jesús Lamas, Oscar Pascual-Marmaneu, Irene Zarra-Ferro
Publikováno v:
Eur J Hosp Pharm
Objective Voriconazole is an antifungal agent used in the treatment of aspergillosis and fluconazole-resistant Candida infections. Therapeutic drug monitoring (TDM) of voriconazole is recommended to optimise clinical results. The aim of this study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becacb347f9e244ba87c2acd24875a1a
https://doi.org/10.1136/ejhpharm-2019-002155
https://doi.org/10.1136/ejhpharm-2019-002155
Autor:
Dolores Belles Medall, Francisco Javier Otero Espinar, María Jesús Lamas, Gema Barbeito Castiñeiras, Aurea Gómez Márquez, Andrés Blanco Hortas, Olalla Maroñas, Goretti Durán Piñeiro, Sara Blanco-Dorado, Belén Bardán García, Ana López-Vizcaíno, Anxo Fernández-Ferreiro, Angel Carracedo, Manuel Campos-Toimil, María Luisa Pérez del Molino Bernal, Irene Zarra Ferro, Ana Latorre-Pellicer, María Teresa Rodríguez Jato
Publikováno v:
PharmacotherapyReferences. 40(1)
Background: Voriconazole, a first-line agent for the treatment of invasive fungal infections, is mainly metabolized by cytochrome P450 (CYP) 2C19. A significant portion of patients fail to achieve therapeutic voriconazole trough concentrations, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51c009f6b7cd9dcbefe1f96353ebad0
https://pubmed.ncbi.nlm.nih.gov/31782536
https://pubmed.ncbi.nlm.nih.gov/31782536
Autor:
Cristina Mondelo-García, Irene Zarra-Ferro, Anxo Fernández-Ferreiro, Antonio Pose-Reino, Luis Valdés, Manuel Taboada-Muñiz, Ana Estany-Gestal, Teresa Cabaleiro, Enrique Bandín-Vilar, Eva Rial-Pensado, Ana Castro-Balado, Iria Varela-Rey, Francisco Cajade-Pascual, María Teresa Rodríguez-Jato, María Teresa Rey-Rilo, Jorge Arca-Suárez, María Sandra Albiñana-Pérez, Pedro Rascado-Sedes, Gema Barbeito-Castiñeiras, Álvaro Mena de Cea, Enrique Alemparte-Pardavila, SePkLin Study Group
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Introduction Linezolid is a broadly used antibiotic to treat complicated infections caused by gram-positive bacteria. Therapeutic drug monitoring of linezolid concentrations is recommended to maximise its efficacy and safety, mainly haematological to
Externí odkaz:
https://doaj.org/article/6484a0f820c44074af2404c5513c7b18